Anthony Cahn

3.0k total citations
61 papers, 1.3k citations indexed

About

Anthony Cahn is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Anthony Cahn has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 18 papers in Physiology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Anthony Cahn's work include Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers), Asthma and respiratory diseases (16 papers) and Inhalation and Respiratory Drug Delivery (13 papers). Anthony Cahn is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers), Asthma and respiratory diseases (16 papers) and Inhalation and Respiratory Drug Delivery (13 papers). Anthony Cahn collaborates with scholars based in United Kingdom, United States and Netherlands. Anthony Cahn's co-authors include Dave Singh, Isabelle Pouliquen, Brian O’Connor, Gerry Hagan, Jean Brooks, Andrew Preece, Adrian Serone, Nicholas Locantore, Edith M. Hessel and Edwin R. Chilvers and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Journal of Allergy and Clinical Immunology.

In The Last Decade

Anthony Cahn

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anthony Cahn United Kingdom	18	684	551	226	199	144	61	1.3k
Thomas Trian France	19	471 0.7×	550 1.0×	384 1.7×	235 1.2×	96 0.7×	40	1.1k
Yasuo To Japan	18	553 0.8×	566 1.0×	199 0.9×	218 1.1×	116 0.8×	49	1.1k
Manfred W. Ziegenhagen Germany	15	716 1.0×	631 1.1×	201 0.9×	137 0.7×	140 1.0×	23	1.1k
Jonathan Ward United Kingdom	15	702 1.0×	890 1.6×	231 1.0×	484 2.4×	95 0.7×	37	1.5k
N. Hizawa Japan	23	554 0.8×	641 1.2×	334 1.5×	325 1.6×	52 0.4×	39	1.4k
Jonathan E. Phillips United States	16	520 0.8×	337 0.6×	343 1.5×	257 1.3×	63 0.4×	42	1.2k
Tsutomu Tamada Japan	17	404 0.6×	315 0.6×	196 0.9×	93 0.5×	70 0.5×	86	854
Stéphane Kirkesseli United States	11	466 0.7×	851 1.5×	92 0.4×	354 1.8×	75 0.5×	16	1.3k
Jiong Yang China	20	243 0.4×	498 0.9×	207 0.9×	483 2.4×	114 0.8×	61	1.2k
Fayong Luo United States	14	552 0.8×	114 0.2×	337 1.5×	156 0.8×	136 0.9×	15	1.1k

Countries citing papers authored by Anthony Cahn

Since Specialization

Citations

This map shows the geographic impact of Anthony Cahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Cahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Cahn more than expected).

Fields of papers citing papers by Anthony Cahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Cahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Cahn. The network helps show where Anthony Cahn may publish in the future.

Co-authorship network of co-authors of Anthony Cahn

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Cahn. A scholar is included among the top collaborators of Anthony Cahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Cahn. Anthony Cahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cahn, Anthony, Nazia Chaudhuri, Allan Clark, et al.. (2025). The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial. BMJ Open. 15(2). e088604–e088604.

Oliver, Victoria, Sarah Siederer, Anthony Cahn, et al.. (2023). Exploring the role of ex vivo metabolism on blood and plasma measurements of oxytocin among women in the third stage of labour: A post hoc study. British Journal of Clinical Pharmacology. 89(12). 3669–3680. 3 indexed citations

Mikolasch, Theresia, Eunice Oballa, Yi Cui, et al.. (2022). Mass spectrometry detection of inhaled drug in distal fibrotic lung. Respiratory Research. 23(1). 118–118. 2 indexed citations

Cahn, Anthony, J. Hamblin, Malcolm Begg, et al.. (2021). An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized Trial. International Journal of COPD. Volume 16. 1607–1619. 12 indexed citations

Fahy, William A., Anthony Cahn, A.G.B. Templeton, et al.. (2021). Nemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging Study. International Journal of COPD. Volume 16. 1637–1646. 12 indexed citations

Young, Alexandra L., Joseph Jacob, Anthony Cahn, et al.. (2020). <p>Thoracic Imaging at Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review</p>. International Journal of COPD. Volume 15. 1751–1787. 8 indexed citations

Hajian, Bita, Jan De Backer, Wim Vos, et al.. (2018). Changes in ventilation–perfusion during and after an COPD exacerbation: an assessment using fluid dynamic modeling. International Journal of COPD. Volume 13. 833–842. 12 indexed citations

Geffen, Wouter H. van, Bita Hajian, Wim Vos, et al.. (2018). Functional respiratory imaging: heterogeneity of acute exacerbations of COPD. International Journal of COPD. Volume 13. 1783–1792. 10 indexed citations

Hammond, Matthew, Allan Clark, Anthony Cahn, et al.. (2018). The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial. Trials. 19(1). 89–89. 17 indexed citations

10.

Wilson, Robert C., et al.. (2018). Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of Nemiralisib Administered via the Ellipta Dry Powder Inhaler to Healthy Subjects. Clinical Therapeutics. 40(8). 1410–1417. 16 indexed citations

11.

Prime, David, Wilfried De Backer, Melanie Hamilton, et al.. (2015). Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA ^® Dry Powder Inhaler. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(6). 486–497. 49 indexed citations

12.

Wilson, Robert C., Anthony Cahn, Jonathan Green, et al.. (2014). Safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single (SD) and repeat (RD) inhaled doses of a novel phosphoinositide 3-kinase δ inhibitor (PI3Kδ), GSK2269557, administered to healthy smokers. European Respiratory Journal. 44(Suppl 58). 3411–3411. 4 indexed citations

13.

Wilson, Robert C., et al.. (2013). Safety, tolerability and pharmacokinetics (PK) of single and repeat nebulised doses of a novel phosphoinositide 3-kinase δ inhibitor (PI3Kδ), GSK2269557, administered to healthy male subjects in a phase I study. European Respiratory Journal. 42(Suppl 57). P729–P729. 6 indexed citations

14.

Kelleher, Dennis, Andrew Preece, Rashmi Mehta, et al.. (2011). Phase II study of once-daily GSK573719 inhalation powder, a new long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD). European Respiratory Journal. 38(Suppl 55). p834–p834. 4 indexed citations

15.

Mehta, Rashmi, Amy Newlands, Dennis Kelleher, et al.. (2011). Safety, pharmacokinetics (PK) and pharmacodynamics (PD) of single doses of GSK573719 inhalation powder, a new long-acting muscarinic antagonist (LAMA), in patients with COPD. European Respiratory Journal. 38(Suppl 55). p822–p822. 7 indexed citations

16.

Singh, Dave, Jean Brooks, Gerry Hagan, Anthony Cahn, & Brian O’Connor. (2008). Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD. Thorax. 63(7). 592–598. 137 indexed citations

17.

Benz, Matthew S., Quan Dong Nguyen, Karen Chu, et al.. (2007). CLEAR-IT-2: Interim Results of the Phase II, Randomized, Controlled Dose-and Interval-Ranging Study of Repeated Intravitreal VEGF Trap Administration in Patients With Neovascular Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 48(13). 4549–4549. 3 indexed citations

18.

Sundaresan, Vasi, Grace Chung, Amanda Heppell-Parton, et al.. (1998). Homozygous deletions at 3p12 in breast and lung cancer. Oncogene. 17(13). 1723–1729. 97 indexed citations

19.

Heppell-Parton, Amanda, Anthony Cahn, Anthony J. Bench, et al.. (1995). Thioredoxin, a mediator of growth inhibition, maps to 9q31. Genomics. 26(2). 379–381. 19 indexed citations

20.

Barker, Roger A. & Anthony Cahn. (1988). Parkinson's Disease: An Autoimmune Process. International Journal of Neuroscience. 43(1-2). 1–7. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact